Our story
Odne AG (formerly Lumendo AG) was founded in 2018 based on a pioneering collaboration between the Swiss Federal Institutes of Technology in Lausanne and Zürich (EPFL and ETH Zürich). Building on licensed breakthrough technologies from these institutions, Odne develops transformative endodontic solutions in close collaboration with leading dental KOLs and academic partners.
Following extensive research and scientific validation, Odne received FDA clearance for OdneFill and OdneCure in 2023, and for OdneClean in 2024. The company launched its U.S. operations through Odne Inc., introducing its technologies via a Priority Access Program at AAE 2024. The U.S. launch of OdneClean followed in 2025, with growing clinical adoption demonstrated through AAE 2026.
Root Preservation Therapy (RPT) reflects Odne’s ambition to develop endodontic solutions that aim to
preserve natural root canal anatomy rather than reshape it, supporting a preservation-focused treatment
philosophy.





